Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing non-myeloablative autologous hematopoietic stem cell transplantation

被引：0
|
作者：
Statkute, L [1 ]
Verda, L [1 ]
Oyama, Y [1 ]
Villa, M [1 ]
Shook, T [1 ]
Clifton, R [1 ]
Krosnjar, N [1 ]
Quigley, K [1 ]
Yaung, K [1 ]
Weppner, C [1 ]
Burt, RK [1 ]
机构：
[1] Northwestern Univ, Dept Med, Div Immunotherapy, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.1980.1980
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1980
引用
收藏
页码：561A / 561A
页数：1
相关论文
共 50 条
  • [41] TRANSPLANTATION OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS IN AUTOIMMUNE LIVER DISEASES
    Ilyassova, B. S.
    BULLETIN OF THE NATIONAL ACADEMY OF SCIENCES OF THE REPUBLIC OF KAZAKHSTAN, 2013, (06): : 56 - 62
  • [42] Autologous blood stem cell transplantation for autoimmune diseases
    Snowden, JA
    Biggs, JC
    Brooks, PM
    LANCET, 1996, 348 (9035): : 1112 - 1113
  • [43] Non-myeloablative autologous hematopoietic stem cell transplantation (HSCT) for relapsing-remitting multiple sclerosis
    Burt, RK
    Oyama, Y
    Statkute, L
    Quigley, K
    Weppner, C
    Verda, L
    BLOOD, 2005, 106 (11) : 822A - 822A
  • [44] STANDARDIZATION OF MOBILIZATION PROTOCOL IS ASSOCIATED WITH SUCCESSFUL COLLECTION OF PERIPHERAL BLOOD STEM CELLS FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH ONCOHEMATOLOGICAL DISEASES
    Kuzjaeva, A. A.
    Gritsaev, S. V.
    Zapreeva, I. M.
    Chubukina, Z. V.
    Potichonova, N. A.
    Abdulkadyrov, K. M.
    HAEMATOLOGICA, 2014, 99 : 722 - 723
  • [45] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
  • [46] Autologous non-myeloablative hematopoietic stem cell transplantation (NST) for severe systemic lupus erythematosus.
    Burt, RK
    Oyama, Y
    Statkute, L
    Krosnjar, N
    Verda, L
    Kowalska, B
    Traynor, AE
    BLOOD, 2004, 104 (11) : 46A - 46A
  • [47] The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span
    Primož Rožman
    GeroScience, 2018, 40 : 221 - 242
  • [48] The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span
    Rozman, Primoz
    GEROSCIENCE, 2018, 40 (03) : 221 - 242
  • [49] Outcome of Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Single Center Summary of 511 Patients
    Burt, Richard K.
    Han, Xiaoqiang
    Quigley, Kathleen
    Balabanov, Roumen
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 89 - 90
  • [50] Non-myeloablative stem cell transplantation in adrenoleukodystrophy
    Kapelushnik, J
    Shapira, Y
    Aker, M
    Hershkoviz, E
    Moser, A
    Selavin, S
    Or, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S51 - S51
12345